This past year, Robin Carhart-Harris of Imperial College London and the colleagues conducted the very first medical trial of utilizing psilocybin to deal with depression, and also got some encouraging results. The trial only involved 12 people with no control group, however the team discovered that after two sessions of psilocybin-aided psychiatric therapy, all the volunteers had reduced signs and symptoms.
Journal reference: Scientific Reports, DOI: 10.1038/s41598-017-13282-7
Magic mushroom enthusiasts have lengthy thought that the drug’s capability to induce profound-feeling experiences could be therapeutically helpful. Brain-imaging studies have proven that psilocybin targets regions of the mind overactive in depression.
“This is further evidence that psilocybin may grow to be effective which are more persistent depression,” states Paul Morrison, of King’s College London. “Developments in this region really are a priority in psychiatry. Many people will go through many years of suffering, which resist all standard therapies.”
More about these topics: